Olanzapine Orally Disintegrating recalls
The FDA has published 3 recalls involving Olanzapine Orally Disintegrating since 2014. The latest was reported on 15 Jun 2022. Most were for potency & assay. Mckesson Medical-Surgical Inc. Corporate Office has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2014
Last 12 months0reported
Class I00% of total
Ongoing0latest 15 Jun 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 33%Class III 2 67%
Why olanzapine orally disintegrating is recalled
Companies
By year
All olanzapine orally disintegrating recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Olanzapine Orally Disintegrating Tablets recalled | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS III | Olanzapine Orally Disintegrating Tablets, 5 mg ( unit dose) recalled | Jubilant Cadista Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Olanzapine Orally Disintegrating Tablets 5 mg recalled by Apotex | Apotex | Potency & Assay | Nationwide |
Should you stop taking Olanzapine Orally Disintegrating?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.